Etubics Corporation products are under development. They consist of biopharmaceuticals (vector vaccines) that will be used to immunize individuals or treat large worldwide populations against infectious agents causing difficult-to-treat diseases such as select cancers, influenza viruses, HIV and malaria. The products will be delivered to the market through existing pipelines.

Patents issued; patent cooperation treaty documents filed and current